Mogling Bio Overview

  • Year Founded
  • 2022

Year Founded

  • Status
  • Private

  • Latest Deal Type
  • Seed

  • Latest Deal Amount
  • $536K

  • Investors
  • 1

Mogling Bio General Information

Description

Operator of a biotechnology firm intended to develop new pharmacological approaches to rejuvenate old stem cells. The company's approach is to inhibit the elevated activity of Cdc42 rejuvenating old stem cells of the hematopoietic system, enabling doctors to treat patients with leukemia and various blood diseases, and strengthen the immune system.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 2900 Reading Road
  • Suite 410
  • Cincinnati, OH 45206
  • United States
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Corporate Office
  • 2900 Reading Road
  • Suite 410
  • Cincinnati, OH 45206
  • United States

Mogling Bio Timeline

2023202420252026
Financing Round

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Mogling Bio Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Seed Round 06-Nov-2023 $536K Completed Generating Revenue
1. Seed Round 26-Oct-2022 Completed Generating Revenue
To view Mogling Bio’s complete valuation and funding history, request access »

Mogling Bio Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Seed II
Seed I
To view Mogling Bio’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Mogling Bio Patents

Mogling Bio Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
AU-2025265680-A1 New compounds for medical use Pending 03-May-2024
WO-2025231227-A1 New compounds for medical use Pending 03-May-2024

Mogling Bio Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds
Kizoo Technology Capital Venture Capital Minority
To view Mogling Bio’s complete investors history, request access »

Mogling Bio FAQs

  • When was Mogling Bio founded?

    Mogling Bio was founded in 2022.

  • Where is Mogling Bio headquartered?

    Mogling Bio is headquartered in Cincinnati, OH.

  • What industry is Mogling Bio in?

    Mogling Bio’s primary industry is Drug Discovery.

  • Is Mogling Bio a private or public company?

    Mogling Bio is a Private company.

  • What is the current valuation of Mogling Bio?

    The current valuation of Mogling Bio is .

  • What is Mogling Bio’s current revenue?

    The current revenue for Mogling Bio is .

  • How much funding has Mogling Bio raised over time?

    Mogling Bio has raised $3.54M.

  • Who are Mogling Bio’s investors?

    Kizoo Technology Capital has invested in Mogling Bio.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process